Monographie - Imipenem-Cilastatin / Relebactam

Son güncelleme :
05/12/2025

Imipenem-Cilastatin / Relebactam

Kimyasal yapı

Ticari isim

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Recarbrio

Almanya, Amerika Birleşik Devletleri, Arjantin, Büyük Britanya, Finlandiya, Fransa, İrlanda, İsveç, İtalya, Japonya, Macaristan, Norveç, Romanya

Kaynaklar : Imipenem-Cilastatin / Relebactam

	tip	yayın
4433	Dergi	Ghazi I.M, El Nekidy W.S, Sood A, Dulku A, Patel R, Patel K. Y-site Administration of Imipenem/Cilastatin/ Relebactam With Common Intravenous Medications Clin Ther 2020 ; 42, 3: 475-485.
4801	Dergi	Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration. Am J Health-Syst Pharm 2024 ;51,1:
4809	Laboratuar	Recarbrio® - Résumé des caractéristiques du produit 2024

Mentions Légales